Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study.
HIV Med. 2023 Sep;24(9):1013-1019. doi: 10.1111/hiv.13500. Epub 2023 May 16.
HIV Med. 2023.
PMID: 37194419
48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort.
Cabello-Ubeda A, de Quirós JCLB, Martín Carbonero L, Sanz J, Vergas J, Mena Á, Torralba M, Hernández Segurado M, Pinto A, Tejerina F, Palmier E, Gutiérrez Á, Vázquez P, Pulido F, Górgolas M.
Cabello-Ubeda A, et al. Among authors: palmier e.
PLoS One. 2022 Nov 21;17(11):e0277606. doi: 10.1371/journal.pone.0277606. eCollection 2022.
PLoS One. 2022.
PMID: 36409695
Free PMC article.
Item in Clipboard
Cite
Cite